Studies have shown that polymorphisms in the COL3A1/rs1800255 and Col6A5/29rs12488457 genes may be associated with the clinical course of atopic dermatitis (AD), potentially influencing both disease severity measured by the SCORAD scale and the intensity of itching. This evidence concerns the gene COL6A5 and Alzheimer disease.